Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02196012 · ClinicalTrials.gov registry record · NA

A Technology-Based Intervention for the Reduction of Overweight and Obesity Among College Students

A NA study of Overweight and Obesity, sponsored by The University of Tennessee, Knoxville.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT02196012: Completed NA study of Overweight and Obesity, sponsored by The University of Tennessee, Knoxville.

NCT02196012 is a NA study of Overweight and Obesity that has completed, run by The University of Tennessee, Knoxville. The registered enrollment target is 23 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02196012, a NA study of Overweight and Obesity, has completed, sponsored by The University of Tennessee, Knoxville.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the feasibility and acceptability and efficacy of a two month technology-based weight loss program for overweight and obese college students.

Conditions Studied

Interventions

  • BEHAVIORAL Intervention group
  • BEHAVIORAL attention control condition

Study Locations (1)

Tennessee

  • University of Tennessee - Knoxville

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2013-09
Est. Completion 2014-06
Phase NA

What the finished NCT02196012 record still lists

NCT02196012 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Intervention group is the first listed.

NCT02196012 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT02196012 about?

NCT02196012 is a clinical study titled "A Technology-Based Intervention for the Reduction of Overweight and Obesity Among College Students". The purpose of this study is to determine the feasibility and acceptability and efficacy of a two month technology-based weight loss program for overweight and obese college students.

What is the current status of trial NCT02196012?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2013-09. Estimated completion is 2014-06.

What conditions does trial NCT02196012 study?

This clinical trial studies the following conditions: Overweight and Obesity.

What interventions are being tested in trial NCT02196012?

The interventions under investigation include: Intervention group (BEHAVIORAL), attention control condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT02196012?

This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02196012 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02196012's enrollment target sits among peer trials

23 102nd of 115 higher than 14 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02196012, the US trial registry maintained by the National Library of Medicine. NCT02196012 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.